Abstract

BackgroundVenous thromboembolism (VTE) is a serious complication following total joint replacement. The use of rivaroxaban, a highly selective and direct factor Xa inhibitor, has been used widely as a safe and efficacious way to prevent VTE after total joint replacements. However, little is known about the diagnostic efficacy of plasma D-dimer test on deep vein thrombosis (DVT) in patients using rivaroxaban for thromboprophylaxis. The study is aimed to investigate the trend and the diagnostic efficacy of D-dimer test on DVT in patients with primary total knee arthroplasty (TKA) using rivaroxaban for thromboprophylaxis.MethodsTwo hundred TKA patients using rivaroxaban postoperatively as chemical prophylaxis were reviewed. D-dimer levels were checked at 4 h after the surgery and on postoperative days 1 and 4. Venography was used to document the presence of DVT. The Mann-Whitney U test was used to detect the differences in the D-dimer levels at different time points in patients with and without DVT, followed by Bonferroni corrections for p values. Receiver operating characteristics (ROC) curves were constructed to determine the best cutoff values of the D-dimer test at each time point after the surgery.ResultsTwenty-nine of the 200 patients were found to have deep vein thrombosis by venography, resulting in an incidence of 14.5%. All patients with DVTs occurred in the distal calf veins, and only one patient was symptomatic. We found significant differences in D-dimer concentration between patients with and without DVT at postoperative day 4. The best cutoff value determined by receiver operating characteristics analysis was 3.8 mg/L at postoperative day 4, with an AUC equal to 63.5%, and a sensitivity, specificity, PPV, and NPV of 58.6, 76, 29.3, and 91.5%, respectively.ConclusionsRivaroxaban was effective on reducing DVT in patients undergoing TKA. Because all the DVTs occurred in the leg veins, decreased thrombus volume and size might result in poor accuracy of plasma D-dimer test in prediction or diagnosis of postoperative DVT.

Highlights

  • Venous thromboembolism (VTE) is a serious complication following total joint replacement

  • Patients were excluded if they had (1) coagulopathy; (2) significant liver disease; (3) severe renal impairment; (4) concomitant use of protease inhibitors of human immunodeficiency virus, or fibrinolytic agents that was contraindicated to the use of rivaroxaban; (5) prior surgery on the affected knee; (6) a history of thromboembolic disease requiring life-long anticoagulant therapy or anti-platelet drugs that could not be stopped before operation, and (7) no venographic report due to technical failure or refusal to receive the exam

  • The incidence of deep vein thrombosis (DVT) DVT was identified by venography in 29 of 200 patients with primary total knee arthroplasty (TKA) resulting in an incidence of 14.5%

Read more

Summary

Introduction

Venous thromboembolism (VTE) is a serious complication following total joint replacement. Little is known about the diagnostic efficacy of plasma Ddimer test on deep vein thrombosis (DVT) in patients using rivaroxaban for thromboprophylaxis. The study is aimed to investigate the trend and the diagnostic efficacy of D-dimer test on DVT in patients with primary total knee arthroplasty (TKA) using rivaroxaban for thromboprophylaxis. Venous thromboembolism (VTE) is a potentially serious complication following total joint replacement. The overall incidence of deep vein thrombosis (DVT) following total joint replacement in patients without thromboprophylaxis ranged around 40~70% in Western countries [1,2,3]. Despite of being considered the gold standard in the diagnosis of DVT in lower extremity [11], venography is a costly and invasive procedure carrying certain risk [3, 12]. The sensitivity of ultrasonography for distal and non-occlusive proximal DVT was reported to be less favorable and operator-dependent [12, 13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call